108 related articles for article (PubMed ID: 29357796)
21. Clinical and molecular aspects of frontotemporal dementia.
Froelich-Fabre S; Skoglund L; Ostojic J; Kilander L; Lindau M; Glaser A; Basun H; Lannfelt L
Neurodegener Dis; 2004; 1(4-5):218-24. PubMed ID: 16908993
[TBL] [Abstract][Full Text] [Related]
22. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.
Lall D; Baloh RH
J Clin Invest; 2017 Sep; 127(9):3250-3258. PubMed ID: 28737506
[TBL] [Abstract][Full Text] [Related]
23. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
Ji AL; Zhang X; Chen WW; Huang WJ
J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
[TBL] [Abstract][Full Text] [Related]
24. Distinct genetic forms of frontotemporal dementia.
Seelaar H; Kamphorst W; Rosso SM; Azmani A; Masdjedi R; de Koning I; Maat-Kievit JA; Anar B; Donker Kaat L; Breedveld GJ; Dooijes D; Rozemuller JM; Bronner IF; Rizzu P; van Swieten JC
Neurology; 2008 Oct; 71(16):1220-6. PubMed ID: 18703462
[TBL] [Abstract][Full Text] [Related]
25. A novel network analysis approach reveals DNA damage, oxidative stress and calcium/cAMP homeostasis-associated biomarkers in frontotemporal dementia.
Palluzzi F; Ferrari R; Graziano F; Novelli V; Rossi G; Galimberti D; Rainero I; Benussi L; Nacmias B; Bruni AC; Cusi D; Salvi E; Borroni B; Grassi M
PLoS One; 2017; 12(10):e0185797. PubMed ID: 29020091
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
[TBL] [Abstract][Full Text] [Related]
27. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
Todd TW; Petrucelli L
J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
[TBL] [Abstract][Full Text] [Related]
28. Parkinsonism, movement disorders and genetics in frontotemporal dementia.
Baizabal-Carvallo JF; Jankovic J
Nat Rev Neurol; 2016 Mar; 12(3):175-85. PubMed ID: 26891767
[TBL] [Abstract][Full Text] [Related]
29. Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.
Janssens J; Philtjens S; Kleinberger G; Van Mossevelde S; van der Zee J; Cacace R; Engelborghs S; Sieben A; Banzhaf-Strathmann J; Dillen L; Merlin C; Cuijt I; Robberecht C; Schmid B; Santens P; Ivanoiu A; Vandenbulcke M; Vandenberghe R; Cras P; De Deyn PP; Martin JJ; Maudsley S; Haass C; Cruts M; Van Broeckhoven C;
Acta Neuropathol Commun; 2015 Nov; 3():68. PubMed ID: 26555887
[TBL] [Abstract][Full Text] [Related]
30. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
31. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.
Suárez-Calvet M; Dols-Icardo O; Lladó A; Sánchez-Valle R; Hernández I; Amer G; Antón-Aguirre S; Alcolea D; Fortea J; Ferrer I; van der Zee J; Dillen L; Van Broeckhoven C; Molinuevo JL; Blesa R; Clarimón J; Lleó A
J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):684-91. PubMed ID: 24309270
[TBL] [Abstract][Full Text] [Related]
32. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
[TBL] [Abstract][Full Text] [Related]
33. The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations.
Liu Y; Yu JT; Sun FR; Ou JR; Qu SB; Tan L
J Neurol Sci; 2013 Dec; 335(1-2):26-35. PubMed ID: 24090760
[TBL] [Abstract][Full Text] [Related]
34. Microtubule associated protein (tau) gene variability in patients with frontotemporal dementia.
Kowalska A; Takahashi K; Kozubski W; Tabira T
Folia Neuropathol; 2002; 40(1):1-5. PubMed ID: 12121033
[TBL] [Abstract][Full Text] [Related]
35. Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.
Luis E; Ortiz A; Eudave L; Ortega-Cubero S; Borroni B; van der Zee J; Gazzina S; Caroppo P; Rubino E; D'Agata F; Le Ber I; Santana I; Cunha G; Almeida MR; Boutoleau-Bretonnière C; Hannequin D; Wallon D; Rainero I; Galimberti D; Van Broeckhoven C; Pastor MA; Pastor P
J Alzheimers Dis; 2016 May; 53(1):303-13. PubMed ID: 27163810
[TBL] [Abstract][Full Text] [Related]
36. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
[TBL] [Abstract][Full Text] [Related]
37. Genetics of Alzheimer's Disease and Frontotemporal Dementia.
Nacmias B; Piaceri I; Bagnoli S; Tedde A; Piacentini S; Sorbi S
Curr Mol Med; 2014; 14(8):993-1000. PubMed ID: 25323872
[TBL] [Abstract][Full Text] [Related]
38. [Frontotemporal dementia: a review].
Chauvire V; Even C; Thuile J; Rouillon F; Guelfi JD
Encephale; 2007 Dec; 33(6):933-40. PubMed ID: 18789785
[TBL] [Abstract][Full Text] [Related]
39. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.
Rosso SM; van Herpen E; Pijnenburg YA; Schoonenboom NS; Scheltens P; Heutink P; van Swieten JC
Arch Neurol; 2003 Sep; 60(9):1209-13. PubMed ID: 12975285
[TBL] [Abstract][Full Text] [Related]
40. Impaired protein degradation in FTLD and related disorders.
Götzl JK; Lang CM; Haass C; Capell A
Ageing Res Rev; 2016 Dec; 32():122-139. PubMed ID: 27166223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
